Of 180 patients with polymyositis/dermatomyositis (PM/DM) seen at the University of Pittsburgh and affiliated hospitals since 1975, 21 of 100 tested positive for the anti-Jo-1 antibody. Sixteen of the 21 patients were women and 18 were white. Fifteen had adult PM, 4 had myositis in overlap with scle
Anti-p53 antibodies in patients with dermatomyositis/polymyositis
β Scribed by Yoshihiro Mimura; Norihito Yazawa; Zenshirou Tamaki; Ryuichi Ashida; Masatoshi Jinnin; Yoshihide Asano; Yayoi Tada; Masahide Kubo; Hironobu Ihn; Kunihiko Tamaki
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 100 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The frequency of clinical and biochemical relapses was determined in a group of 50 patients with polymyositis (PM), dermatomyositis (DM), or overlap syndromes who were followed for periods of up to 13 years. Relapses occurred in 30 of the 50 patients (60%) during the period of followup. The annual r
We report 3 patients with polymyositis and the anti-Jo-1 antibody who developed fatal adult respiratory distress syndrome (ARDS). Other than the presence of the anti-Jo-1 antibody, there were no other consistent clinical features at the onset of disease that were predictive of ARDS development.